Skip to Main Content

Mentorship

Evidence suggests that traditional one-to-one mentoring approaches are not as effective as team mentoring approaches, where mentors with different skills, experiences, and knowledge bases provide mentoring to early career investigators. Team mentoring provides Fellows with access to mentors that may have strengths in different content and professional areas to provide Fellows with a wealth of advice. We utilize a team mentoring system where Pre- and Post-Doctoral Fellows are mentored by Primary and Secondary Mentors. In addition, Peer Mentors (Yale CPC Training Program alumni) will mentor Post-Doctoral Fellows, and Post- Doctoral Fellows will mentor Pre-Doctoral Fellows. The Yale CPC Training Program Steering Committee will provide training and support to Primary, Secondary, and Peer Mentors. In addition to the regular meetings between a Fellow and one or two Mentors, each Fellow will meet with all Mentors together at least once a year.

Individual Development Plan (IDP): Upon entry in the Yale CPC Training Program, each Fellow will work with their Mentoring Team and the Steering Committee to design an IDP. The IDP will be tailored based on each fellow’s background, research interests, career goals and mentors’ guidance and resources. The IDP process will be a two-way interaction between Fellows, Mentors, and Steering Committee. The plan will be evaluated every 6 months and updated as necessary. The IDP will identify a research project and laboratory or clinical environment for the Fellow to work in, create personalized didactic plans, set expectations and timelines, assist in the transition to independent lab space when appropriate, and provide guidance to transition fellows off the T32 and onto support from an individual career development award.

The Mentoring Team will use the IDPs to monitor the Fellows’ progress and will review and provide input on manuscripts and grant proposals. The Mentoring Team will also ensure coordination of each Fellow being trained in our five thematic areas. Mentors will verify that 1) the Fellow is receiving the appropriate training for a successful career in CPC; 2) the research is of sufficient rigor and quality to provide an outstanding training opportunity; 3) the research is progressing well and when necessary, changes in research plans are made; and 4) career development is suitable for the level of the Fellow and that the Fellow will reach expected milestones such as manuscript and grant submission and scientific presentations. The mentorship team will be available to the Fellow to review drafts of scholarly documents including grants and manuscripts and provide constructive feedback.

Primary Faculty

  • Professor of Biostatistics; Director of Medical Research, School of Public Health

    Research Interests
    • Glioma
    • Epidemiology
    • Breast Neoplasms
    • Central Nervous System Neoplasms
    • Astrocytoma
    • Oligodendroglioma
    • Neurosurgery
    • Meningioma
    • Statistics as Topic
    Elizabeth B. Claus, MD, PhD is Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston. She is a member of the board of advisors for the Acoustic Neuroma Association (ANA) as well as the Central Brain Tumor Registry of the United States (CBTRUS). Dr. Claus' work is focused in cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall PI of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In addition to her research activities, Dr. Claus...
  • Associate Professor of Epidemiology (Chronic Diseases); Co-Director, Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health; Director of Graduate Studies, Yale School of Public Health

    Research Interests
    • Leukemia
    • Genetic Pleiotropy
    • Epidemiology
    • Genetics
    • Asthma
    • Biostatistics
    • Chronic Disease
    • Pre-Eclampsia
    • Norway
    • Sepsis
    Andrew DeWan is a genetic epidemiologist with a focus on extending and applying analytical methods to identify genetic susceptibility variants for complex traits. A key theme throughout his work is applying a strategy of delineating narrowly defined phenotypes and stratification by ancestry to reduce heterogeneity and increase statistical power. To better elucidate the genetic architecture of complex traits, his research extends analytical methods to identify genetic interactions as well as pleiotropy. He has applied these genetic mapping methods across a number of diverse phenotypes including asthma, obesity, leukemia, pediatric lung cancer, preeclampsia, preterm birth, and bacterial bloodstream infections. He has been the Principal Investigator of external grants to fund his research (5 NIH grants, including three R01s). He is the Co-Director of the Yale Center for Perinatal, Pediatric...
  • Associate Professor of Epidemiology (Environmental Health Sciences); Co-Director, Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE)

    Dr. Deziel obtained a Master’s of Industrial Hygiene and Doctorate in Environmental Health from the Johns Hopkins Bloomberg School of Public Health. Her research is focused on applying statistical models, biomonitoring techniques, and environmental measurements to provide comprehensive and quantitative assessments of exposure to traditional and emerging environmental contaminants in population-based studies. Her research uses a combination of large, administrative datasets and detailed community-focused studies to advance understanding of environmental exposures to chemicals, particularly carcinogens and endocrine disruptors. This research also serves to illuminate exposure mechanisms underlying associations between environmental chemicals and disease, thereby informing more effective policies to reduce exposures and protect public health. Dr....
  • Assistant Professor of Epidemiology (Chronic Diseases)

    Research Interests
    • Tanning
    • Skin Neoplasms
    • Survivors
    • Public Health
    • Metabolomics
    • Diet
    • Epidemiology
    • Colorectal Neoplasms
    • Chronic Disease
    • Breast Neoplasms
    Leah M. Ferrucci, PhD, MPH is an assistant professor at the Yale School of Public Health. Dr. Ferrucci earned her BA from the University of Pennsylvania and her MPH in the Social and Behavioral Sciences at the Yale School of Public Health. She received a PhD in nutritional cancer epidemiology through a joint training program with Yale University and the National Cancer Institute. Throughout her career, Dr. Ferrucci has focused on modifiable cancer risk factors, including nutrition and ultraviolet radiation related exposures, as well as cancer survivorship. She has worked not only in the study of the etiology of early-onset basal cell carcinoma (e.g. indoor tanning, alcohol intake, tea, coffee, and caffeine), but also translating these findings into behavioral interventions to reduce indoor tanning in young women and adolescent girls. Dr. Ferrucci is also studying diet quality, obesity,...
  • Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases); Founder and Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine; Director, National Clinician Scholars Program

    Research Interests
    • Epidemiology
    • Ethics, Research
    • Chronic Disease
    • Internal Medicine
    • Health Policy
    Dr. Cary Gross is a Professor of Medicine and Public Health, and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year. His research addresses comparative effectiveness, quality, and health equity, with a focus on cancer prevention and treatment. He aims to use real-world research to generate knowledge that will inform change in clinical care and health policy. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in...
  • Associate Dean of Research and Susan Dwight Bliss Professor of Epidemiology (Chronic Diseases); Deputy Director (Public Health), Yale Center for Clinical Investigation; Deputy Director, Yale Cancer Center

    Research Interests
    • Breast Neoplasms
    • Neoplasms by Histologic Type
    • Exercise
    • Ovarian Neoplasms
    • Obesity
    • Weight Loss
    Melinda L. Irwin, PhD, MPH is the Susan Dwight Bliss Professor of Epidemiology and Associate Dean of Research at the Yale School of Public Health, Deputy Director of the Yale Cancer Center, and Deputy Director (Public Health) in the Yale Center for Clinical Investigation. Nationally, Dr. Irwin co-leads the SWOG Cancer Research Network Cancer Survivorship Committee. In 2018, Dr. Irwin completed the yearlong Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program. Dr. Irwin’s experience working across departments, schools, and with interdisciplinary groups of investigators has provided her with the skills to train and mentor effectively. Dr. Irwin is a prominent leader in the field of cancer prevention and survivorship research. Her research over the past 20 years has focused on randomized trials of exercise and weight loss on biological markers,...
  • Associate Professor of Epidemiology (Environmental Health Sciences)

    Research Interests
    • Environmental Exposure
    • Biostatistics
    • Mass Spectrometry
    • Metabolomics
    Caroline H. Johnson, PhD, is a Tenured Associate Professor of Epidemiology in the Department of Environmental Health Sciences at Yale School of Public Health. She graduated from Imperial College London in 2009 with a PhD in Analytical Chemistry. Since then she has held postdoctoral and staff appointments at the National Cancer Institute and The Scripps Research Institute. Dr. Johnson's research uses mass spectrometry-based metabolomics to understand the role of metabolites in human health. Her primary research interest is to investigate the relationship between genetic and environmental influences (diet, hormones and microbiome) in colon cancer. She is also examining exposures during pregnancy.
  • Albert E. Kent Professor of Psychiatry; Chair, Human Investigations Committee (IRB), Human Research Protections Program; Professor, Chronic Disease Epidemiology

    Research Interests
    • Substance-Related Disorders
    • Tobacco
    • Tobacco Use Disorder
    • Smoking Cessation
    • Psychiatry and Psychology
    • Psychotherapy
    • Nicotine
    • Marijuana Abuse
    • Marijuana Use
    • Adolescent Psychiatry
    • Alcohol-Related Disorders
    • Alcohol Drinking
    • Behavioral Medicine
    Dr. Suchitra Krishnan-Sarin is a Professor of Psychiatry at the Yale University School of Medicine. She is also a Chair of the Human Investigations Committee (IRB) at Yale. Her research is focused on developing a bio-behavioral understanding of substance use behaviors in adult and adolescent substance users, with the goal of developing optimal prevention and cessation interventions. In the area of adolescent tobacco use, her research focuses on understanding the appeal, abuse potential and patterns of use of tobacco products, developing and testing the use of novel behavioral and pharmacological cessation and prevention interventions, and understanding behavioral and neural predictors of use and cessation behaviors. She has contributed to the Surgeon General’s reports on youth tobacco use behaviors, served as a member of the FDA’s Tobacco Product Scientific Advisory...
  • Department Chair and Professor of Biostatistics; Affiliated Faculty, Yale Institute for Global Health; Director, Biostatistics and Bioinformatics Shared Resource

    Research Interests
    • Economics
    • Biostatistics
    • Neoplasms
    Dr. Ma received his Ph.D. degree in statistics at University of Wisconsin in 2004. Prior to arriving at Yale, Dr. Ma was a Senior Fellow in Collaborative Health Studies Coordinating Center (CHSCC) and Department of Biostatistics at University of Washington. He has been involved in developing novel statistical and bioinformatics methodologies for analysis of cancer (NHL, breast cancer, melanoma, lung cancer), mental disorders, and cardiovascular diseases. He has also been involved in health economics research, with special interest in health insurance in developing countries.
  • Interim Department Chair and Professor of Epidemiology (Chronic Diseases); Co-Leader, Cancer Prevention and Control

    Research Interests
    • Neoplasms
    • Myelodysplastic Syndromes
    • Myeloproliferative Disorders
    • Lymphoma
    • Leukemia
    • Chronic Disease
    • Epidemiology
    Dr. Ma is Professor of Epidemiology at the Yale School of Public Health, and Co-Leader of the Cancer Prevention and Control Research Program at the Yale Comprehensive Cancer Center, Yale School of Medicine. She studies the etiology and health outcomes of different types of cancer, with a focus on pediatric cancer and malignancies of the hematopoietic system (e.g., leukemia, lymphoma, myelodysplastic syndromes, and myeloproliferative neoplasms). Her research has addressed the impact of immunological factors, chemical exposures, and genetic characteristics on the risk of cancer. In addition, she has assessed the patterns of care and cost implications of cancer screening and treatment in older adults.
  • Associate Dean for Academic Affairs and Professor of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health; Director, HPV Working Group at Yale; Director, CT Emerging Infections Program at Yale, Epidemiology of Microbial Diseases

    Research Interests
    • Epidemiologic Methods
    • Epidemiology
    • HIV
    • Sexually Transmitted Diseases
    • Vaccines
    • Communicable Diseases, Emerging
    • Qualitative Research
    • Human papillomavirus 11
    Linda Niccolai is the Associate Dean for Academic Affairs at Yale School of Public Health and Professor in the Department of Epidemiology of Microbial Diseases. She is an internationally recognized scholar in infectious disease epidemiology with specific interests in vaccine-preventable diseases and sexually transmitted infections. Her vaccinology research focuses on understanding uptake, impact, and effectiveness of HPV and other adolescent vaccines with an emphasis on addressing health disparities. Her STI research focuses on social and behavioral aspects of transmission dynamics and prevention. Funded by a diverse grant portfolio (NIH, CDC, and private foundations), her work is interdisciplinary by design and includes behavioral and clinical epidemiology, surveillance, and qualitative approaches. As Director of the CT Emerging Infections at Yale, she oversees a large program of...
  • Associate Dean for Health Equity Research and C.N.H. Long Professor of Internal Medicine (General Medicine), of Epidemiology (Chronic Disease) and of Public Health (Social And Behavioral Sciences) & Professor of Internal Medicine (General Medicine); Affiliated Faculty, Yale Institute for Global Health; Founding Director, Equity Research and Innovation Center (ERIC), Yale School of Medicine; Director, Center for Research Engagement (CRE); Director, Center for Community Engagement and Health Equity; Deputy Director for Health Equity Research and Workforce Development, Yale Center for Clinical Investigation (YCCI); Director, Pozen-Commonwealth Fund Fellowship in Health Equity Leadership

    Research Interests
    • Internal Medicine
    • Minority Health
    • Population Health
    • Patient Reported Outcome Measures
    • Community-Based Participatory Research
    • COVID-19
    • Chronic Disease
    • Caribbean Region
    • Health Services Research
    • Healthcare Disparities
    • Global Burden of Disease
    • Global Health
    • Social Determinants of Health
    • Social Discrimination
    • Social Justice
    • Socioeconomic Factors
    • Vulnerable Populations
    • Women's Health
    Dr. Nunez-Smith is Inaugural Associate Dean for Health Equity Research; C.N.H Long Professor of Internal Medicine, Public Health, and Management; Founding Director of the Equity Research and Innovation Center (ERIC); Director of the Center for Research Engagement (CRE); Associate Cancer Center Director for Community Outreach and Engagement at Yale Cancer Center; Chief Health Equity Officer at Smilow Cancer Hospital; Deputy Director for Health Equity Research and Workforce Development at the Yale Center for Clinical Investigation; Core Faculty in the National Clinician Scholars Program; Research Faculty in the Global Health Leadership Initiative; Director of the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership; and Co-Director of the Doris Duke Clinical Research Fellowship. Dr. Nunez-Smith’s research focuses on promoting health and healthcare equity for structurally...
  • Professor Emeritus and Senior Research Scientist in Epidemiology (Chronic Diseases); Affiliated Faculty, Yale Institute for Global Health

    Research Interests
    • Helicobacter pylori
    • Host-Pathogen Interactions
    • Germ-Line Mutation
    • Gonadal Steroid Hormones
    • Esophageal Neoplasms
    • Stomach Neoplasms
    • Molecular Epidemiology
    • Polymorphism, Genetic
    • Ovarian Neoplasms
    • Pancreatic Neoplasms
    Dr. Harvey Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. Dr. Risch received his MD degree from the University of California San Diego and PhD, in mathematical modeling of infectious epidemics, from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale in 1991. Dr. Risch's research interests are in the areas of cancer etiology, prevention and early diagnosis, and in epidemiologic methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, histopathologic factors, occupational/environmental/medication exposures, infection and immune functioning in cancer etiology...
  • Susan Dwight Bliss Professor of Biostatistics; Director, Center for Methods in Implementation and Prevention Science (CMIPS); Professor of Statistics and Data Science; Professor of Medicine (Cardiovascular Medicine); Assistant Director, Global Oncology, Yale Cancer Center

    Research Interests
    • Biostatistics
    • Cardiovascular Diseases
    • Clinical Trial
    • Epidemiologic Methods
    • Global Health
    • Health Plan Implementation
    • HIV Infections
    • Implementation Science
    • Maternal Mortality
    • Obesity
    Donna Spiegelman was appointed the Susan Dwight Bliss Professor of Biostatistics at the Yale School of Public Health in 2018; she is also Professor of Statistics and Data Science at Yale University. Dr. Spiegelman founded and directs the Yale Center for Methods in Implementation and Prevention Science (CMIPS) and she also leads the Global Oncology program at Yale Cancer Center. As one of the few people in the world with a joint doctorate in biostatistics and epidemiology, she can freely speak the languages of both disciplines and switches between these two professional cultures, playing the role of interlocutor for each. She is interested in problems arising in epidemiology that require resolution, at least in part, through biostatistics. The emerging field of implementation science is among Dr. Spiegelman's major areas of interest. This field examines barriers to the implementation of...
  • Department Chair and Susan Dwight Bliss Professor of Epidemiology (Environmental Health Sciences) and of Ophthalmology and Visual Science and of Environment; Director, Yale Superfund Research Center; Affiliated Faculty, Yale Cancer Center; Affiliated Faculty, Yale Institute for Global Health; Co-Director, Environmental Health Sciences Track, Executive MPH

    Research Interests
    • Ophthalmology
    • Mass Spectrometry
    • Genomics
    • Glutathione
    • Gout
    • Environmental Health
    • Alcoholism
    • Aldehyde Dehydrogenase
    • Diabetes Mellitus
    Vasilis Vasiliou, is Professor and Chair of the Department of Environmental Health Sciences. He received his BSc in Chemistry (1983) and PhD in Biochemical Pharmacology (1988) from the University of Ioannina, Greece. He then trained in gene-environment interactions, molecular toxicology and pharmacogenetics at the Department of Environmental Health in the College of Medicine at the University of Cincinnati (1991-1995). In 1996, he joined the faculty of the University of Colorado School of Pharmacy where he rose through the ranks to become Professor and Director of the Toxicology Graduate Program. Since 2008, he was also Professor of Ophthalmology at the University of Colorado School of Medicine. In July 2014, he joined the faculty of Yale University in his new position.Professor Vasiliou has established an internationally-recognized research program that has been...
  • Senior Research Scientist in Epidemiology

    Research Interests
    • Terminal Care
    • Breast Neoplasms
    Dr. Wang is an Associate Professor at the Yale School of Public Health, faculty member of Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, and faculty member of Public Health Modeling Concentration, Yale School of Public Health. His primary interests focus on outcomes research and decision science. He is interested in combining systematic literature reviews, secondary data analyses, and simulation modeling to examine issues that are critical to clinicians and policy makers’ decision making. He has been working on several breast cancer projects, including an evaluation of preoperative breast MRI, development of an individualized decision aid to help radiotherapy decision-making, and assessment of sentinel lymph node biopsy for patients with ductal carcinoma in situ. He is also evaluating end-of-life care quality. He has served as the primary investigator or...
  • Ira V. Hiscock Professor of Biostatistics, Professor of Genetics and Professor of Statistics and Data Science

    Research Interests
    • Genetics
    • Public Health
    • Computational Biology
    • Statistics
    • Genomics
    • Proteomics
    • Biostatistics
    • Single-Cell Analysis
    • Microbiota
    • Wearable Electronic Devices
    Dr. Hongyu Zhao is the Ira V. Hiscock Professor of Biostatistics and Professor of Statistics and Data Science and Genetics. He received his B.S. in Probability and Statistics from Peking University in 1990 and Ph.D. in Statistics from the University of California at Berkeley in 1995. His research interests are the developments and applications of novel statistical methods to address scientific questions in genetics, molecular biology, drug developments, and precision medicine. Some of his recent projects include large scale genome wide studies to identify genetic variants underlying complex diseases, genetic risk prediction, single cell analysis, biological network modeling and analysis, disease biomarker identification, genome annotation, cancer genomics, microbiome analysis, image analysis, and wearable device data analysis. He has published over 700 articles in statistics,...
  • Associate Professor Emeritus of Epidemiology; Track Director, Environmental Health Sciences, Executive MPH; Assistant Director, Global Epidemiology

    Research Interests
    • Breast Neoplasms
    • Environmental Health
    • Genetics, Medical
    • Public Health
    • Testicular Neoplasms
    • Molecular Epidemiology
    Dr. Yong Zhu is an Associate Professor at Yale University School of Public Health and Assistant Director of Yale Cancer Center for Global Cancer Epidemiology. Dr. Zhu's research interests are oriented towards the use of the molecular epidemiological approach in the study of genetic susceptibility biomarkers and their interactions with environmental exposures in human disease development. Dr. Zhu has been developing and validating novel phenotypic and genotypic assays and biomarkers for several cancer types, including non-Hodgkin's Lymphoma, breast, bladder, lung and prostate cancer. By utilizing various techniques in genetics, epigenetics, cytogenetics, cell biology, and computational biology, his studies have identified biomarkers that can characterize inherited predisposition and cellular response to environmental factors. Current research focuses on studying the...

Resource Faculty

  • Associate Professor Adjunct

    Research Interests
    • Breast
    Dr. Adelson is an Adjunct Associate Professor and was previously Chief Quality Officer for Yale Cancer Center and Smilow Cancer Hospital. Dr. Adelson graduated from Yale University School of Medicine, completed residency at Mount Sinai Medical Center and Fellowship in oncology at Columbia Presbyterian. In her Quality role, Dr. Adelson focused on improving care coordination for all patients treated in the Smilow network, aligning care with national quality metrics, and developing models to enhance patient involvement in decisions about their cancer-care. Dr. Adelson sits on several national committees including the Southwest Oncology group Cancer Delivery Committee, the National Cancer Care Network Policy Committee and the American Society of Clinical Oncology Health Information Technology Committee.
  • Senior Research Scientist in and Lecturer in Epidemiology (Chronic Diseases)

    Research Interests
    • Tanning
    • Stress, Psychological
    • Nutrition Disorders
    • Nutritional Sciences
    • Ovarian Neoplasms
    • Carcinoma
    • Epidemiology
    • Chronic Disease
    • Disease-Free Survival
    Dr. Cartmel's primary research interests are in the area of cancer prevention and cancer survivorship. Dr. Cartmel is Co-Leader for the 'Personalized Intervention Program: Tobacco Treatment for Lung Cancer Screening Patients (PIP), one of four projects which are part of the Yale Lung SPORE (PI: Dr. Roy Herbst).  In addition to this study, Dr. Cartmel is involved in several diet and exercise intervention studies in cancer survivors (Melinda Irwin Ph.D. and Tara Sanft, M.D. PIs).  She is also participating in a nationwide longitudinal quality of life study in cancer survivors in which she is studying communication of health information to long-term cancer survivors. Other interests include the use of a novel noninvasive assessment method of skin carotenoids and skin cancer etiology and prevention, including work on tanning addiction.
  • Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry

    Research Interests
    • Vulnerable Populations
    • Technology
    • Tertiary Prevention
    • Tobacco Use
    • Tobacco Use Cessation
    • Secondary Prevention
    • Sleep
    • Sleep Hygiene
    • Sedentary Behavior
    • Harm Reduction
    • Health Risk Behaviors
    • Nicotine
    • Mobile Applications
    • Exercise
    • Alcohol Drinking
    • Alcoholism
    I am an expert in tobacco and hazardous alcohol use, other modifiable lifestyle risk behaviors (i.e., deficient sleep, and physical inactivity), and digital health technology. My research focuses on: 1) better understanding and predicting these risks; 2) phenotyping risk variability within individuals; 3) developing novel lifestyle interventions that are tailored to these unique risk profiles; and 4) implementing lifestyle risk behavior/mental health screening and intervention in clinical settings. I utilize various technologies including biosensors, smartphones, telehealth, and electronic health record tools to monitor these behaviors, derive integrated biometric feedback, deliver interventions, and improve healthcare. In addition, I am interested in digitally-derived endpoints as alternative endpoints for clinical trials. In a separate and distinct line of research, I study the effects of different tobacco products...
  • Associate Professor of Internal Medicine (Hematology); Chief Quality Officer, Smilow Cancer Hospital and Yale Cancer Center; Chief, Inpatient Cancer Medicine

    Research Interests
    • Lymphoma
    • Hematologic Diseases
    • Insurance
    Scott Huntington, MD, MPH is a clinician and researcher at the Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia. He is an Associate Professor of Medicine (Hematology) and the Medical Director of Yale Cancer Center's Hematology Outpatient Program. Prior to joining Yale, he completed his hematology-oncology training and received a Master of Science in Health Policy Research at the University of Pennsylvania. Dr. Huntington serves as an investigator on clinical trials evaluating novel cancer therapeutics and is an active member of Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment during routine care.
  • Research Scientist in and Lecturer in Epidemiology (Chronic Diseases); Inaugural Director, Cancer Screening & Prevention Program

    Research Interests
    • Epidemiologic Factors
    • Health Care
    • Breast Neoplasms
    • Neoplasms
    • Minority Health
    • Health Status Disparities
    • Healthcare Disparities
    • Health Care Quality, Access, and Evaluation
    • Social Class
    • Social Determinants of Health
    • Socioeconomic Factors
    • Secondary Prevention
    • Primary Prevention
    Dr. Jones is a Yale-trained cancer epidemiologist whose work and teaching focus is on health disparities. Her research is primarily focused on racial/ethnic differences in cancer screening, prevention, and cancer outcomes. A recently completed study tested 4 evidence-based interventions to address overdue colorectal cancer screening in a large urban primary care clinic. Ongoing projects include working with Implementation Science research teams to address system and patient level factors that compromise the full benefit of cervical cancer screening in minority populations and in developing mitigation strategies to protect respiratory health in large clinical workplace. Other projects focus on the impact of COVID-19 on adults and GEN-Z populations in at-risk communities with implications for cancer prevention and screening behaviors. In leadership roles in Community Outreach...
  • Associate Professor of Urology; Clinical Program Leader, Prostate & Urologic Cancers Program, Yale Cancer Center; Assistant Professor, Chronic Disease Epidemiology

    Research Interests
    • Delivery of Health Care
    • Health Services Research
    • Kidney Diseases
    • Ureteral Diseases
    • Urinary Bladder Diseases
    • Urologic Neoplasms
    • Prostatic Neoplasms
    Clinical interests: Prostate cancer: low-risk prostate cancer, active surveillance, nerve-sparing robotic prostatectomy, focal therapy, high-risk disease, pelvic lymph node dissection, imaging, risk stratification; molecular imaging; PSMA; focal therapy; bladder cancer: intravesical therapy, TURBT, radical cystectomy with urinary diversion, continent urinary diversion, neobladder, ileal conduit. Kidney cancer: laparoscopic radical nephrectomy, laparoscopic partial nephrectomy, robotic partial nephrectomy, open radical nephrectomy, open partial nephrectomy. Testicular cancer. Upper tract urothelial carcinoma: laparoscopic, open nephroureterectomy, ureterectomy Watch a video with Dr. Michael Leapman >>Michael Leapman, MD was drawn to the field of urology for the opportunity to care for patients with urologic cancers. He aims, above all, to deliver the highest level of care possible with the...
  • Elizabeth Mears and House Jameson Professor of Psychiatry; Deputy Chair, Clinical Research

    Research Interests
    • Substance-Related Disorders
    • Risk Reduction Behavior
    • Smoking
    • Psychiatry and Psychology
    • Psychiatry
    • Alcoholism
  • Associate Professor of Medicine (Medical Oncology); Chief, Patient Experience Officer; Medical Director, Survivorship Clinic

    Research Interests
    • Communication
    • Breast Diseases
    • Survivorship
    I am board certified in both medical oncology and hospice and palliative medicine, which I feel helps me treat the "whole person" and not just a disease. As the Chief Patient Experience Officer at Smilow Cancer Hospital, I enjoy thinking about improving care, especially where the provider and patient experience overlaps. As a breast oncologist, I have a busy practice and enjoy taking care of women with newly diagnosed breast cancer. As the director of the Yale Survivorship Clinic, one of the nation’s only multi-disciplinary clinics specializing in cancer survivorship, I learn from patients about key issues after treatment and this informs my role as Chair of the NCCN Survivorship Guidelines. My research focuses on healthy lifestyles and quality of life after cancer. I am a facilitator for Relationship-Centered Communication Workshop that address how we develop therapeutic relationships with our patients...
  • Associate Professor, Obstetrics, Gynecology and Reproductive Sciences; Interim Division Director, Gynecologic Specialties; Vice Chair of Diversity, Equity, & Inclusion (DEI), Obstetrics, Gynecology & Reproductive Sciences; Director of Colposcopy and Cervical Dysplasia, Gynecologic Specialties

    Research Interests
    • Contraception
    • Global Health
    • Gynecology
    • Adolescent
    • Pregnancy
    • Papanicolaou Test
    • Nepal
    • Obstetrics
    • Information Dissemination
    • Mexico
    • Maternal Mortality
    • Human papillomavirus 16
    • Health Plan Implementation
    • HIV
    • Reproductive Medicine
    • Uterine Cervical Dysplasia
    • Women's Health
    As a member of the winning research team for Yale’s 2015 Excellence in Educational Innovation Prize, Dr. Sangini S. Sheth is equally at home caring for patients and mentoring young doctors. She serves as an associate professor of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. “I deeply enjoy the great breadth and depth of Ob/Gyn,” says Sheth. “Discussing preventative medicine in clinic one day and performing complex surgery with advanced technology the next.”A native of Connecticut, Dr. Sheth graduated cum laude from Yale University and returned to her alma mater in 2013 after receiving her MD and MPH from the Johns Hopkins School of Medicine and Bloomberg School of Public Health. In clinical practice, she is passionate about providing a full range of gynecologic services to women in all stages of life, from cervical cancer prevention and...
  • Professor of Medicine (Medical Oncology)

    Research Interests
    • Breast
    Dr. Silber is the Associate CEHE Director for Clinical Research. As a medical oncologist who serves as the Medical Director and Physician Champion of the Centers for Disease Control/Connecticut Department of Public Health's 5-year provider supported grant at Yale New Haven Hospital entitled, The Connecticut Cancer Screening Program (CCSP), she designed the Comprehensive Breast Cancer Outreach and Support Program for Underserved Women, which is a culturally competent program supported by the Breast Cancer Alliance of Greenwich. She has supervised Community Health Educators dating back to 1996, when she received a national Komen award for the Sister to Sister Program, and has been recognized for expertise in breast cancer among African American women. She has directed a cancer clinic for the uninsured and underinsured for two decades and have formed...
  • Professor Adjunct of Epidemiology (Microbial Diseases)

    Research Interests
    • Child Health
    • Environment and Public Health
    • Global Health
    • HIV
    • Women's Health
    • Public Health
    Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle income countries. His work on HIV-HPV interactions among women in Bronx methadone programs motivated a change in the 1993 CDC AIDS case surveillance definition and inspired cervical cancer screening programs launched within HIV/AIDS programs around the world. The thrust of his research has focused on health care access, adolescent sexual and reproductive health and rights, and prevention of  HIV transmission among general and key populations, including mother-to-child.  Dr. Vermund has become increasingly engaged in health policy, particularly around sustainability of HIV/AIDS programs and their expansion to non-communicable diseases, coronavirus pandemic response and prevention, and public health workforce development. His recent grants include...
  • Assistant Professor Adjunct

    Research Interests
    • Head and Neck Neoplasms
    • Central Nervous System Neoplasms
    • Breast Neoplasms
    • Radiotherapy, Intensity-Modulated
    • Urogenital Neoplasms
    James Yu, MD, MHS, is Professor of Radiation Oncology and Genitourinary Cancers Radiotherapy Lead at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. He is a former Professor of Radiation Oncology at the Yale School of Medicine, former Associate Chief Medical Officer of the Smilow Cancer Hospital and Care Centers and Executive Vice Chair of Columbia University Irving Medical Center Department of Radiation Oncology. In his academic work, Dr. Yu conducts research on ways to use radiotherapy treatments to improve outcomes for cancer patients. “We need to push the field ever forward and not be satisfied with merely prolonging survival,” says Dr. Yu. “I think radiosurgery will play a role in this. As systemic therapies improve and our ability to control microscopically disseminated disease improves, noninvasive ablative therapies will become ever more important.”...